DE69512279D1 - Verfahren zur herstellung von spirolaxin und spirolaxinmethylether - Google Patents

Verfahren zur herstellung von spirolaxin und spirolaxinmethylether

Info

Publication number
DE69512279D1
DE69512279D1 DE69512279T DE69512279T DE69512279D1 DE 69512279 D1 DE69512279 D1 DE 69512279D1 DE 69512279 T DE69512279 T DE 69512279T DE 69512279 T DE69512279 T DE 69512279T DE 69512279 D1 DE69512279 D1 DE 69512279D1
Authority
DE
Germany
Prior art keywords
spirolaxin
atcc
pct
methyl ether
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69512279T
Other languages
English (en)
Other versions
DE69512279T2 (de
Inventor
Mark Guadliana
Liang Huang
Takushi Kaneko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69512279D1 publication Critical patent/DE69512279D1/de
Publication of DE69512279T2 publication Critical patent/DE69512279T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69512279T 1995-03-30 1995-03-30 Verfahren zur herstellung von spirolaxin und spirolaxinmethylether Expired - Fee Related DE69512279T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000217 WO1996030538A1 (en) 1995-03-30 1995-03-30 Process for preparing spirolaxine and spirolaxine methyl ether

Publications (2)

Publication Number Publication Date
DE69512279D1 true DE69512279D1 (de) 1999-10-21
DE69512279T2 DE69512279T2 (de) 1999-12-30

Family

ID=11004322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69512279T Expired - Fee Related DE69512279T2 (de) 1995-03-30 1995-03-30 Verfahren zur herstellung von spirolaxin und spirolaxinmethylether

Country Status (12)

Country Link
US (1) US6074855A (de)
EP (1) EP0817863B1 (de)
JP (1) JP3078845B2 (de)
AT (1) ATE184650T1 (de)
AU (1) AU691738B2 (de)
CA (1) CA2214871C (de)
DE (1) DE69512279T2 (de)
DK (1) DK0817863T3 (de)
ES (1) ES2135710T3 (de)
FI (1) FI973831A (de)
GR (1) GR3031213T3 (de)
WO (1) WO1996030538A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2867384B1 (fr) * 2004-03-15 2008-10-17 Lvmh Rech Compositions cosmetiques et dermatologiques a activite depigmentante

Also Published As

Publication number Publication date
US6074855A (en) 2000-06-13
EP0817863B1 (de) 1999-09-15
DK0817863T3 (da) 1999-12-20
FI973831A0 (fi) 1997-09-29
DE69512279T2 (de) 1999-12-30
ES2135710T3 (es) 1999-11-01
CA2214871A1 (en) 1996-10-03
AU5040596A (en) 1996-10-10
JPH10509051A (ja) 1998-09-08
FI973831A (fi) 1997-09-29
AU691738B2 (en) 1998-05-21
WO1996030538A1 (en) 1996-10-03
ATE184650T1 (de) 1999-10-15
EP0817863A1 (de) 1998-01-14
GR3031213T3 (en) 1999-12-31
CA2214871C (en) 2002-02-12
JP3078845B2 (ja) 2000-08-21

Similar Documents

Publication Publication Date Title
NO2015027I1 (no) Mepolizumab
DE59602230D1 (de) Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
DE69522436D1 (de) Verfahren zur herstellung von äthylalkohol
DE59606782D1 (de) Fachwerk und gefacheelement und verfarhren zur herstellung eines gefacheelements
DE69715841D1 (de) Phosphatidsäure enthaltende zusammensetzungen
DE69513847D1 (de) Verfahren zur herstellung von substituierten 3-aminobenzonitrilen
DE69703796T2 (de) N-bis- oder n-tris-[(1,2-dicarboxy-ethoxy)-ethyl]-amin-derivate und herstellung und anwendung derselben
ATE224149T1 (de) Verfahren zur herstellung von stabilen trüben extrakten
DE69512279D1 (de) Verfahren zur herstellung von spirolaxin und spirolaxinmethylether
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
ATE205473T1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE69414586T2 (de) Verfahren zur herstellung von indolizinderivaten
DE59706904D1 (de) Verfahren zur herstellung von ivermectin
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE175668T1 (de) Verfahren zur herstellung von 8-g(a),12-oxido- 13,14,15,16-tetranorlabdan
DE3767843D1 (de) Verfahren zur herstellung von 2-brom-1',2'-dichloroperfluordiethylether.
DE69514115D1 (de) Verfahren zur herstellung von levobupivacain und analogue aus l-lysin
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
ATE250078T1 (de) Verfahren zur herstellung von 4,4-dimethyl-5 alpha-cholesta-8,14,24-trien-3 beta-ol und zwischenprodukte im verfahren (i)
ATE247618T1 (de) Verfahren zur herstellung von 1,4-diaryl-2-fluor- 1,3-butadien- und 1,4-diaryl-2-fluor-2- butenverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee